Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation: past, present and future

E D Thomas1

  • 1Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

Stem Cells (Dayton, Ohio)
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.

Transplantation·1992
Same author

Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.

Genomics·1992
Same author

Bone marrow transplantation: past experiences and future prospects.

Seminars in oncology·1992
Same author

Donor alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission.

European journal of haematology·1992
Same author

Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

Bone marrow transplantation·1992
Same author

Acceptance of the George M. Kober Medal.

Transactions of the Association of American Physicians·1992

Human marrow transplants have evolved significantly, with success rates improving dramatically since the 1950s. Advances in donor matching, stem cell collection, and supportive therapies enhance outcomes for various diseases.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Early human allogeneic marrow transplants in the mid-20th century faced significant challenges and low success rates.
  • Significant advancements in transplantation medicine over the last two decades have markedly improved patient outcomes.
  • Graft-versus-host disease and disease stage heavily influence transplant success probabilities.

Observation:

  • Cure rates vary widely, from 90% for early nonmalignant diseases to 15% for advanced leukemia.
  • Historically reliant on HLA-matched sibling donors, marrow transplantation now utilizes matched unrelated donors via programs like the National Marrow Donor Program.
  • Research focuses on novel preparative regimens, graft-versus-host disease prevention, and hematopoietic growth factors.

Findings:

Related Experiment Videos

  • Hematopoietic stem cells, crucial for marrow regeneration, have been isolated and characterized.
  • Peripheral blood stem cells, mobilized by chemotherapy or growth factors, are increasingly used for transplantation.
  • Technological innovations facilitate shorter hospital stays and reduced costs associated with marrow transplants.

Implications:

  • Improved donor availability through registries expands treatment options for patients lacking family donors.
  • Ongoing research promises further refinements in transplant efficacy and patient safety.
  • The increasing use of autologous transplants and peripheral stem cells signifies a shift towards more personalized and efficient therapeutic strategies.